世界の抗レトロウイルス薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antiretroviral Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5589
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、抗レトロウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（多剤併用、NRTI、NNRTI、プロテアーゼ阻害剤、その他）、用途別市場規模（病院、製薬会社、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・抗レトロウイルス薬の市場動向
・企業の競争状況、市場シェア
・抗レトロウイルス薬の種類別市場規模と予測2016-2027（多剤併用、NRTI、NNRTI、プロテアーゼ阻害剤、その他）
・抗レトロウイルス薬の用途別市場規模と予測2016-2027（病院、製薬会社、その他）
・抗レトロウイルス薬の北米市場規模2016-2027（アメリカ、カナダ）
・抗レトロウイルス薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗レトロウイルス薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗レトロウイルス薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗レトロウイルス薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Gilead Sciences、ViiV Healthcare、Bristol-Myer Squibb、AbbVie、Boehringer-Ingelheim、Johnson and Johnson、Merck、CIPLA）
・結論

Tire-derived fuel (TDF) is composed of shredded scrap tires.

Market Analysis and Insights: Global Antiretroviral Drug Market
The global Antiretroviral Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antiretroviral Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antiretroviral Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antiretroviral Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antiretroviral Drug market.

Global Antiretroviral Drug Scope and Market Size
Antiretroviral Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiretroviral Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Multi-Class Drugs Combination
NRTI
NNRTI
Protease Inhibitors
Other

Segment by Application
Hospital
Pharmaceutical Companies
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Gilead Sciences
ViiV Healthcare
Bristol-Myer Squibb
AbbVie
Boehringer-Ingelheim
Johnson and Johnson
Merck
CIPLA

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiretroviral Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Multi-Class Drugs Combination
1.2.3 NRTI
1.2.4 NNRTI
1.2.5 Protease Inhibitors
1.2.6 Other
1.3 Market by Application
1.3.1 Global Antiretroviral Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antiretroviral Drug Market Perspective (2016-2027)
2.2 Antiretroviral Drug Growth Trends by Regions
2.2.1 Antiretroviral Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antiretroviral Drug Historic Market Share by Regions (2016-2021)
2.2.3 Antiretroviral Drug Forecasted Market Size by Regions (2022-2027)
2.3 Antiretroviral Drug Industry Dynamic
2.3.1 Antiretroviral Drug Market Trends
2.3.2 Antiretroviral Drug Market Drivers
2.3.3 Antiretroviral Drug Market Challenges
2.3.4 Antiretroviral Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antiretroviral Drug Players by Revenue
3.1.1 Global Top Antiretroviral Drug Players by Revenue (2016-2021)
3.1.2 Global Antiretroviral Drug Revenue Market Share by Players (2016-2021)
3.2 Global Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antiretroviral Drug Revenue
3.4 Global Antiretroviral Drug Market Concentration Ratio
3.4.1 Global Antiretroviral Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiretroviral Drug Revenue in 2020
3.5 Antiretroviral Drug Key Players Head office and Area Served
3.6 Key Players Antiretroviral Drug Product Solution and Service
3.7 Date of Enter into Antiretroviral Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antiretroviral Drug Breakdown Data by Type
4.1 Global Antiretroviral Drug Historic Market Size by Type (2016-2021)
4.2 Global Antiretroviral Drug Forecasted Market Size by Type (2022-2027)

5 Antiretroviral Drug Breakdown Data by Application
5.1 Global Antiretroviral Drug Historic Market Size by Application (2016-2021)
5.2 Global Antiretroviral Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antiretroviral Drug Market Size (2016-2027)
6.2 North America Antiretroviral Drug Market Size by Type
6.2.1 North America Antiretroviral Drug Market Size by Type (2016-2021)
6.2.2 North America Antiretroviral Drug Market Size by Type (2022-2027)
6.2.3 North America Antiretroviral Drug Market Size by Type (2016-2027)
6.3 North America Antiretroviral Drug Market Size by Application
6.3.1 North America Antiretroviral Drug Market Size by Application (2016-2021)
6.3.2 North America Antiretroviral Drug Market Size by Application (2022-2027)
6.3.3 North America Antiretroviral Drug Market Size by Application (2016-2027)
6.4 North America Antiretroviral Drug Market Size by Country
6.4.1 North America Antiretroviral Drug Market Size by Country (2016-2021)
6.4.2 North America Antiretroviral Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antiretroviral Drug Market Size (2016-2027)
7.2 Europe Antiretroviral Drug Market Size by Type
7.2.1 Europe Antiretroviral Drug Market Size by Type (2016-2021)
7.2.2 Europe Antiretroviral Drug Market Size by Type (2022-2027)
7.2.3 Europe Antiretroviral Drug Market Size by Type (2016-2027)
7.3 Europe Antiretroviral Drug Market Size by Application
7.3.1 Europe Antiretroviral Drug Market Size by Application (2016-2021)
7.3.2 Europe Antiretroviral Drug Market Size by Application (2022-2027)
7.3.3 Europe Antiretroviral Drug Market Size by Application (2016-2027)
7.4 Europe Antiretroviral Drug Market Size by Country
7.4.1 Europe Antiretroviral Drug Market Size by Country (2016-2021)
7.4.2 Europe Antiretroviral Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antiretroviral Drug Market Size (2016-2027)
8.2 Asia-Pacific Antiretroviral Drug Market Size by Type
8.2.1 Asia-Pacific Antiretroviral Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antiretroviral Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antiretroviral Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Antiretroviral Drug Market Size by Application
8.3.1 Asia-Pacific Antiretroviral Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antiretroviral Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antiretroviral Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Antiretroviral Drug Market Size by Region
8.4.1 Asia-Pacific Antiretroviral Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antiretroviral Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antiretroviral Drug Market Size (2016-2027)
9.2 Latin America Antiretroviral Drug Market Size by Type
9.2.1 Latin America Antiretroviral Drug Market Size by Type (2016-2021)
9.2.2 Latin America Antiretroviral Drug Market Size by Type (2022-2027)
9.2.3 Latin America Antiretroviral Drug Market Size by Type (2016-2027)
9.3 Latin America Antiretroviral Drug Market Size by Application
9.3.1 Latin America Antiretroviral Drug Market Size by Application (2016-2021)
9.3.2 Latin America Antiretroviral Drug Market Size by Application (2022-2027)
9.3.3 Latin America Antiretroviral Drug Market Size by Application (2016-2027)
9.4 Latin America Antiretroviral Drug Market Size by Country
9.4.1 Latin America Antiretroviral Drug Market Size by Country (2016-2021)
9.4.2 Latin America Antiretroviral Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antiretroviral Drug Market Size (2016-2027)
10.2 Middle East & Africa Antiretroviral Drug Market Size by Type
10.2.1 Middle East & Africa Antiretroviral Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antiretroviral Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antiretroviral Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Antiretroviral Drug Market Size by Application
10.3.1 Middle East & Africa Antiretroviral Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antiretroviral Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antiretroviral Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Antiretroviral Drug Market Size by Country
10.4.1 Middle East & Africa Antiretroviral Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antiretroviral Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Antiretroviral Drug Introduction
11.1.4 Gilead Sciences Revenue in Antiretroviral Drug Business (2016-2021)
11.1.5 Gilead Sciences Recent Development
11.2 ViiV Healthcare
11.2.1 ViiV Healthcare Company Details
11.2.2 ViiV Healthcare Business Overview
11.2.3 ViiV Healthcare Antiretroviral Drug Introduction
11.2.4 ViiV Healthcare Revenue in Antiretroviral Drug Business (2016-2021)
11.2.5 ViiV Healthcare Recent Development
11.3 Bristol-Myer Squibb
11.3.1 Bristol-Myer Squibb Company Details
11.3.2 Bristol-Myer Squibb Business Overview
11.3.3 Bristol-Myer Squibb Antiretroviral Drug Introduction
11.3.4 Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2016-2021)
11.3.5 Bristol-Myer Squibb Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Antiretroviral Drug Introduction
11.4.4 AbbVie Revenue in Antiretroviral Drug Business (2016-2021)
11.4.5 AbbVie Recent Development
11.5 Boehringer-Ingelheim
11.5.1 Boehringer-Ingelheim Company Details
11.5.2 Boehringer-Ingelheim Business Overview
11.5.3 Boehringer-Ingelheim Antiretroviral Drug Introduction
11.5.4 Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2016-2021)
11.5.5 Boehringer-Ingelheim Recent Development
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Antiretroviral Drug Introduction
11.6.4 Johnson and Johnson Revenue in Antiretroviral Drug Business (2016-2021)
11.6.5 Johnson and Johnson Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Antiretroviral Drug Introduction
11.7.4 Merck Revenue in Antiretroviral Drug Business (2016-2021)
11.7.5 Merck Recent Development
11.8 CIPLA
11.8.1 CIPLA Company Details
11.8.2 CIPLA Business Overview
11.8.3 CIPLA Antiretroviral Drug Introduction
11.8.4 CIPLA Revenue in Antiretroviral Drug Business (2016-2021)
11.8.5 CIPLA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antiretroviral Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Multi-Class Drugs Combination
Table 3. Key Players of NRTI
Table 4. Key Players of NNRTI
Table 5. Key Players of Protease Inhibitors
Table 6. Key Players of Other
Table 7. Global Antiretroviral Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Antiretroviral Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Antiretroviral Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Antiretroviral Drug Market Share by Regions (2016-2021)
Table 11. Global Antiretroviral Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Antiretroviral Drug Market Share by Regions (2022-2027)
Table 13. Antiretroviral Drug Market Trends
Table 14. Antiretroviral Drug Market Drivers
Table 15. Antiretroviral Drug Market Challenges
Table 16. Antiretroviral Drug Market Restraints
Table 17. Global Antiretroviral Drug Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Antiretroviral Drug Market Share by Players (2016-2021)
Table 19. Global Top Antiretroviral Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Drug as of 2020)
Table 20. Ranking of Global Top Antiretroviral Drug Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Antiretroviral Drug Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Antiretroviral Drug Product Solution and Service
Table 24. Date of Enter into Antiretroviral Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Antiretroviral Drug Revenue Market Share by Type (2016-2021)
Table 28. Global Antiretroviral Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Antiretroviral Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Antiretroviral Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Antiretroviral Drug Revenue Market Share by Application (2016-2021)
Table 32. Global Antiretroviral Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Antiretroviral Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Antiretroviral Drug Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Antiretroviral Drug Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Antiretroviral Drug Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Antiretroviral Drug Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Antiretroviral Drug Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Antiretroviral Drug Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Antiretroviral Drug Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Antiretroviral Drug Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Antiretroviral Drug Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Antiretroviral Drug Market Size by Country (2022-2027) & (US$ Million)
Table 64. Gilead Sciences Company Details
Table 65. Gilead Sciences Business Overview
Table 66. Gilead Sciences Antiretroviral Drug Product
Table 67. Gilead Sciences Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million)
Table 68. Gilead Sciences Recent Development
Table 69. ViiV Healthcare Company Details
Table 70. ViiV Healthcare Business Overview
Table 71. ViiV Healthcare Antiretroviral Drug Product
Table 72. ViiV Healthcare Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million)
Table 73. ViiV Healthcare Recent Development
Table 74. Bristol-Myer Squibb Company Details
Table 75. Bristol-Myer Squibb Business Overview
Table 76. Bristol-Myer Squibb Antiretroviral Drug Product
Table 77. Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million)
Table 78. Bristol-Myer Squibb Recent Development
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Antiretroviral Drug Product
Table 82. AbbVie Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million)
Table 83. AbbVie Recent Development
Table 84. Boehringer-Ingelheim Company Details
Table 85. Boehringer-Ingelheim Business Overview
Table 86. Boehringer-Ingelheim Antiretroviral Drug Product
Table 87. Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million)
Table 88. Boehringer-Ingelheim Recent Development
Table 89. Johnson and Johnson Company Details
Table 90. Johnson and Johnson Business Overview
Table 91. Johnson and Johnson Antiretroviral Drug Product
Table 92. Johnson and Johnson Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million)
Table 93. Johnson and Johnson Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Antiretroviral Drug Product
Table 97. Merck Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million)
Table 98. Merck Recent Development
Table 99. CIPLA Company Details
Table 100. CIPLA Business Overview
Table 101. CIPLA Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million)
Table 102. CIPLA Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiretroviral Drug Market Share by Type: 2020 VS 2027
Figure 2. Multi-Class Drugs Combination Features
Figure 3. NRTI Features
Figure 4. NNRTI Features
Figure 5. Protease Inhibitors Features
Figure 6. Other Features
Figure 7. Global Antiretroviral Drug Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Other Case Studies
Figure 11. Antiretroviral Drug Report Years Considered
Figure 12. Global Antiretroviral Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Antiretroviral Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Antiretroviral Drug Market Share by Regions: 2020 VS 2027
Figure 15. Global Antiretroviral Drug Market Share by Regions (2022-2027)
Figure 16. Global Antiretroviral Drug Market Share by Players in 2020
Figure 17. Global Top Antiretroviral Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Drug as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Antiretroviral Drug Revenue in 2020
Figure 19. Global Antiretroviral Drug Revenue Market Share by Type (2016-2021)
Figure 20. Global Antiretroviral Drug Revenue Market Share by Type (2022-2027)
Figure 21. North America Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Antiretroviral Drug Market Share by Type (2016-2027)
Figure 23. North America Antiretroviral Drug Market Share by Application (2016-2027)
Figure 24. North America Antiretroviral Drug Market Share by Country (2016-2027)
Figure 25. United States Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Antiretroviral Drug Market Share by Type (2016-2027)
Figure 29. Europe Antiretroviral Drug Market Share by Application (2016-2027)
Figure 30. Europe Antiretroviral Drug Market Share by Country (2016-2027)
Figure 31. Germany Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Antiretroviral Drug Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Antiretroviral Drug Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Antiretroviral Drug Market Share by Region (2016-2027)
Figure 41. China Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Antiretroviral Drug Market Share by Type (2016-2027)
Figure 49. Latin America Antiretroviral Drug Market Share by Application (2016-2027)
Figure 50. Latin America Antiretroviral Drug Market Share by Country (2016-2027)
Figure 51. Mexico Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Antiretroviral Drug Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Antiretroviral Drug Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Antiretroviral Drug Market Share by Country (2016-2027)
Figure 57. Turkey Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Gilead Sciences Revenue Growth Rate in Antiretroviral Drug Business (2016-2021)
Figure 61. ViiV Healthcare Revenue Growth Rate in Antiretroviral Drug Business (2016-2021)
Figure 62. Bristol-Myer Squibb Revenue Growth Rate in Antiretroviral Drug Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Antiretroviral Drug Business (2016-2021)
Figure 64. Boehringer-Ingelheim Revenue Growth Rate in Antiretroviral Drug Business (2016-2021)
Figure 65. Johnson and Johnson Revenue Growth Rate in Antiretroviral Drug Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Antiretroviral Drug Business (2016-2021)
Figure 67. CIPLA Revenue Growth Rate in Antiretroviral Drug Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界のアテローム性動脈硬化症薬市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Drug Market Size, Status and Forecast 2021-2027
QFJ1-3865 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗血小板薬、コレステロール低下薬、フィブリン酸＆オメガ-3脂肪酸誘導体、その他）、用途別市場規模（小売薬局、病院薬局、オンライン...

世界の皮膚放射線傷害治療薬市場規模・現状・予測（2021年-2027年）

Global Cutaneous Radiation Injury Drug Market Size, Status and Forecast 2021-2027
QFJ1-4082 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、皮膚放射線傷害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のB型肝炎治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Drug Market Size, Status and Forecast 2021-2027
QFJ1-5776 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）、...

世界のB型肝炎用治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5777 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）...

世界の鎮痙薬市場規模・現状・予測（2021年-2027年）

Global Antispasmodics Drug Market Size, Status and Forecast 2021-2027
QFJ1-3839 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、鎮痙薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジシクロミン塩酸塩、ロペラミド塩酸塩、その他）、用途別市場規模（病院、ホームケア、専門診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
世界の向精神薬市場規模・現状・予測（2021年-2027年） The majority of essential psychotropic drugs are indicated to treat symptoms of mental disorders, slow down course of mental disorders, diminish disability and avoid relapse in a patient. Market Analysis and Insights: Global Psychotropic Drug Market The global Psychotropic Drug market size is projec…
世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年） Palbociclib is a drug manufactured by Pfizer, marketed under the brand Ibrance, and it is used for the treatment of hormone receptor-positive (HR+ve) and human epidermal growth factor receptor 2-negative (HER2-), advanced or metastatic breast cancer. It inhibits the activity of cyclin dependent kina…